These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7858884)

  • 21. Sulphonylureas do not increase insulin secretion by a mechanism other than a rise in cytoplasmic Ca2+ in pancreatic B-cells.
    Garcia-Barrado MJ; Jonas JC; Gilon P; Henquin JC
    Eur J Pharmacol; 1996 Mar; 298(3):279-86. PubMed ID: 8846827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of the insulin-releasing action of alpha-ketoisocaproate and related alpha-keto acid anions.
    Heissig H; Urban KA; Hastedt K; Zünkler BJ; Panten U
    Mol Pharmacol; 2005 Oct; 68(4):1097-105. PubMed ID: 16014804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of repaglinide on cloned beta cell, cardiac and smooth muscle types of ATP-sensitive potassium channels.
    Dabrowski M; Wahl P; Holmes WE; Ashcroft FM
    Diabetologia; 2001 Jun; 44(6):747-56. PubMed ID: 11440368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of the sulfonylurea receptor on beta cell membranes.
    Gaines KL; Hamilton S; Boyd AE
    J Biol Chem; 1988 Feb; 263(6):2589-92. PubMed ID: 3125168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pancreatic beta-cell K(ATP) channel activity and membrane-binding studies with nateglinide: A comparison with sulfonylureas and repaglinide.
    Hu S; Wang S; Fanelli B; Bell PA; Dunning BE; Geisse S; Schmitz R; Boettcher BR
    J Pharmacol Exp Ther; 2000 May; 293(2):444-52. PubMed ID: 10773014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenine nucleotide-induced inhibition of binding of sulphonylureas to their receptor in pancreatic islets.
    Schwanstecher M; Löser S; Brandt C; Scheffer K; Rosenberger F; Panten U
    Br J Pharmacol; 1992 Mar; 105(3):531-4. PubMed ID: 1628141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of ATP-sensitive K+ channels in cardiac muscle by the sulphonylurea drug glibenclamide.
    Findlay I
    J Pharmacol Exp Ther; 1992 May; 261(2):540-5. PubMed ID: 1578371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracellular location of KATP channels and sulphonylurea receptors in the pancreatic beta-cell: new targets for oral antidiabetic agents.
    Quesada I; Soria B
    Curr Med Chem; 2004 Oct; 11(20):2707-16. PubMed ID: 15544471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tolbutamide-sensitivity of the adenosine 5'-triphosphate-dependent K+ channel in mouse pancreatic B-cells.
    Panten U; Heipel C; Rosenberger F; Scheffer K; Zünkler BJ; Schwanstecher C
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Nov; 342(5):566-74. PubMed ID: 2090953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The high-affinity sulphonylurea receptor regulates KATP channels in nerve terminals of the rat motor cortex.
    Lee K; Dixon AK; Rowe IC; Ashford ML; Richardson PJ
    J Neurochem; 1996 Jun; 66(6):2562-71. PubMed ID: 8632183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of protein phosphorylation on the sulphonylurea receptor of the pancreatic beta-cell.
    Niki I; Coles B; Ashcroft FM; Ashcroft SJ
    Adv Exp Med Biol; 1997; 426():59-69. PubMed ID: 9544256
    [No Abstract]   [Full Text] [Related]  

  • 32. Insulin secretion from isolated rat islets induced by the novel hypoglycemic agent A-4166, a derivative of D-phenylalanine.
    Tsukuda K; Sakurada M; Niki I; Oka Y; Kikuchi M
    Horm Metab Res; 1998 Jan; 30(1):42-9. PubMed ID: 9503038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin secretion and its modulation by antiarrhythmic and sulfonylurea drugs.
    Horie M; Ishida-Takahashi A; Ai T; Nishimoto T; Tsuura Y; Ishida H; Seino Y; Sasayama S
    Cardiovasc Res; 1997 Apr; 34(1):69-72. PubMed ID: 9217874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The sulphonylurea receptor may be an ATP-sensitive potassium channel.
    Sturgess NC; Ashford ML; Cook DL; Hales CN
    Lancet; 1985 Aug; 2(8453):474-5. PubMed ID: 2412077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization and solubilization of the sulphonylurea receptor in rat brain.
    Niki I; Ashcroft SJ
    Neuropharmacology; 1993 Oct; 32(10):951-7. PubMed ID: 8295717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do adipocytes contain high affinity sulfonylurea receptors.
    Rajan AS; Luo ZT; Kahn BB; Comstock JP; Cushman SW; Boyd AE
    Endocrinology; 1994 Mar; 134(3):1581-8. PubMed ID: 8119201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Taurine block of cloned ATP-sensitive K+ channels with different sulfonylurea receptor subunits expressed in Xenopus laevis oocytes.
    Lim JG; Lee HY; Yun JE; Kim SP; Park JW; Suh SI; Jang BC; Cho CH; Bae JH; Kim SS; Han J; Park MJ; Song DK
    Biochem Pharmacol; 2004 Sep; 68(5):901-10. PubMed ID: 15294453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a 38-kDa high affinity sulfonylurea-binding peptide in insulin-secreting cells and cerebral cortex.
    Schwanstecher M; Löser S; Chudziak F; Panten U
    J Biol Chem; 1994 Jul; 269(27):17768-71. PubMed ID: 8027029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sensitivity of Kir6.2-SUR1 currents, in the absence and presence of sodium azide, to the K(ATP) channel inhibitors, ciclazindol and englitazone.
    McKay NG; Kinsella JM; Campbell CM; Ashford ML
    Br J Pharmacol; 2000 Jun; 130(4):857-66. PubMed ID: 10864893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alterations of insulin secretion from mouse islets treated with sulphonylureas: perturbations of Ca2+ regulation prevail over changes in insulin content.
    Anello M; Gilon P; Henquin JC
    Br J Pharmacol; 1999 Aug; 127(8):1883-91. PubMed ID: 10482920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.